Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Share-based Compensation (2020 - 2026)

Updated

Celularity (CELU) posted Share-based Compensation of $844,000 for Q2 2026, down 65.5% from $2.45 million a year earlier and down 32.1% from the prior quarter.

Analysis

Celularity (CELU) Share-based Compensation (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Celularity was $5.81 million, down 45.7% year-over-year; for FY2025, it was $10.38 million, down 10.3% from FY2024.

  • Annual Share-based Compensation has declined for four consecutive years, though with a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
  • In prior years, Celularity's Share-based Compensation was $11.57 million in FY2024 (-23.0%), $15.02 million in FY2023 (-5.3%), $15.86 million in FY2022 (-60.4%) and $40.01 million in FY2021 (+815.4%).
  • Quarterly Share-based Compensation has run from a low of $471,000 in Q3 2025 to a high of $8.88 million in Q3 2021 over five years.
  • On a year-over-year basis, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 32.9%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2022, with growth of 140.0%; the weakest was Q2 2022, with a decline of 83.9%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $1.24 million (Q1 2026), $3.25 million (Q4 2025) and $471,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 166.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 231.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 249.00 Mn
10 Celularity 30.75 Mn 23.50 Mn 3.09 Mn 844,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 844,000.00
Mar 31, 2026 1.37 Mn
Dec 31, 2025 3.25 Mn
Sep 30, 2025 471,000.00
Jun 30, 2025 108,000.00
Mar 31, 2025 2.64 Mn
Dec 31, 2024 2.94 Mn
Sep 30, 2024 2.67 Mn
Jun 30, 2024 2.99 Mn
Mar 31, 2024 2.97 Mn
Dec 31, 2023 3.58 Mn
Sep 30, 2023 3.60 Mn
Jun 30, 2023 3.86 Mn
Mar 31, 2023 3.99 Mn
Dec 31, 2022 4.39 Mn
Sep 30, 2022 4.52 Mn
Jun 30, 2022 4.53 Mn
Mar 31, 2022 2.42 Mn
Dec 31, 2021 1.93 Mn
Sep 30, 2021 8.88 Mn
API Access

Celularity Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CELU&period=max&api_key=YOUR_API_KEY